Hypertension study: Nifedipine and Enalapril vs Nifedipine and Labetalol
Official title Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension Study
ClinicalTrials.gov ID: NCT07363343
What this study is testing
What is Nifedipine and Enalapril?
This is an investigational combination of two blood pressure medicines being studied to see if it helps control high blood pressure after giving birth. Nifedipine is designed to relax blood vessels, while enalapril is designed to help the body remove extra salt and water and relax blood vessels.
Also referred to as Procardia and Vasotec.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study wants to find out if one combination of blood pressure medicines controls pressure better than another after giving birth.
- Who it's for
- The study is looking for people who have high blood pressure or a condition called preeclampsia after having a baby.
- What's involved
- Participants will take one of two different pairs of blood pressure pills and have their blood pressure checked regularly.
- Time commitment
- The source text does not specify how long the study lasts or how many visits are needed.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Postpartum women aged 18 years or older
- Clinical diagnosis of hypertensive disorder in pregnancy (gestational hypertension, chronic hypertension, preeclampsia with or without severe...
- Taking Nifedipine 60 mg every 12 hours for blood pressure control
- Persistently elevated blood pressure at/above 140/90 mmHg in a 24-hour time period or have one or more severe range blood pressure at/above 160/110...
- English speaking
You likely can't join if
- Taking ≥2 antihypertensive agents during pregnancy
- Heart block
- Heart rate \ 120 beats per minute
- Heart failure
- Creatinine \>1.5 mg/dL
- Renal artery stenosis
See the full eligibility criteria
- Postpartum women aged 18 years or older
- Clinical diagnosis of hypertensive disorder in pregnancy (gestational hypertension, chronic hypertension, preeclampsia with or without severe features)
- Taking Nifedipine 60 mg every 12 hours for blood pressure control
- Persistently elevated blood pressure at/above 140/90 mmHg in a 24-hour time period or have one or more severe range blood pressure at/above 160/110 mmHg requiring a second antihypertensive medication
- English speaking
- Taking ≥2 antihypertensive agents during pregnancy
- Heart block
- Heart rate \ 120 beats per minute
- Heart failure
- Creatinine \>1.5 mg/dL
- Renal artery stenosis
- Active connective tissue disease
- Cerebrovascular accident
- Failed treatment or contraindications to nifedipine, enalapril or labetalol
The study team makes the final eligibility decision.
Where it is enrolling
- Cleveland, Ohio, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Cleveland, Ohio, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.